Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared Friday. Why it matters: That’s good news for Novo Nordisk (whose sto… [+1427 chars]Read More
Ozempic and Wegovy shortage ends setting up weight loss drug showdown Axios
